233 related articles for article (PubMed ID: 30447009)
1. Long noncoding RNA MIR31HG is a bona fide prognostic marker with colorectal cancer cell-intrinsic properties.
Eide PW; Eilertsen IA; Sveen A; Lothe RA
Int J Cancer; 2019 Jun; 144(11):2843-2853. PubMed ID: 30447009
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer.
Wu S; Nitschke K; Worst TS; Fierek A; Weis CA; Eckstein M; Porubsky S; Kriegmair M; Erben P
J Exp Clin Cancer Res; 2020 Dec; 39(1):288. PubMed ID: 33334367
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MIR31HG overexpression serves as poor prognostic biomarker and promotes cells proliferation in lung adenocarcinoma.
Qin J; Ning H; Zhou Y; Hu Y; Yang L; Huang R
Biomed Pharmacother; 2018 Mar; 99():363-368. PubMed ID: 29367106
[TBL] [Abstract][Full Text] [Related]
4. CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer.
Smeby J; Sveen A; Merok MA; Danielsen SA; Eilertsen IA; Guren MG; Dienstmann R; Nesbakken A; Lothe RA
Ann Oncol; 2018 May; 29(5):1227-1234. PubMed ID: 29518181
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer.
Matsuyama T; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kawano T; Uetake H; Goel A
Mol Cancer; 2019 Feb; 18(1):19. PubMed ID: 30717807
[TBL] [Abstract][Full Text] [Related]
6. Association of Consensus Molecular Subtypes and Molecular Markers With Clinical Outcomes in Patients With Metastatic Colorectal Cancer: Biomarker Analyses From LUME-Colon 1.
Lenz HJ; Argiles G; Yoshino T; Tejpar S; Ciardiello F; Braunger J; Salnikov AV; Gabrielyan O; Schmid R; Höfler J; Kitzing T; Van Cutsem E
Clin Colorectal Cancer; 2021 Mar; 20(1):84-95.e8. PubMed ID: 33041226
[TBL] [Abstract][Full Text] [Related]
7. A novel mesenchymal-associated transcriptomic signature for risk-stratification and therapeutic response prediction in colorectal cancer.
Matsuyama T; Kandimalla R; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kinugasa Y; Hansen TF; Fakih M; Uetake H; Győrffy B; Goel A
Int J Cancer; 2020 Dec; 147(11):3250-3261. PubMed ID: 32657428
[TBL] [Abstract][Full Text] [Related]
8. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
[TBL] [Abstract][Full Text] [Related]
9. MIR31HG exhibits oncogenic property and acts as a sponge for miR-361-3p in cervical carcinoma.
Li Y
Biochem Biophys Res Commun; 2020 Sep; 529(4):890-897. PubMed ID: 32819595
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA MIR31HG is activated by SP1 and promotes cell migration and invasion by sponging miR-214 in NSCLC.
Dandan W; Jianliang C; Haiyan H; Hang M; Xuedong L
Gene; 2019 Apr; 692():223-230. PubMed ID: 30659947
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA RP11-59H7.3 promotes cell proliferation and invasion metastasis in colorectal cancer by miR-139-5p/NOTCH1 axis.
Zhu X; Luo C; Bu F; Lin K; Zhu Z
Aging (Albany NY); 2020 Jun; 12(12):11653-11666. PubMed ID: 32507766
[TBL] [Abstract][Full Text] [Related]
12. An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
Wang XJ; Zeng B; Lin S; Chen M; Chi P
Ann Clin Lab Sci; 2019 Nov; 49(6):730-739. PubMed ID: 31882423
[TBL] [Abstract][Full Text] [Related]
13. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A
Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692
[TBL] [Abstract][Full Text] [Related]
14. SNHG17 promotes colorectal tumorigenesis and metastasis via regulating Trim23-PES1 axis and miR-339-5p-FOSL2-SNHG17 positive feedback loop.
Bian Z; Zhou M; Cui K; Yang F; Cao Y; Sun S; Liu B; Gong L; Li J; Wang X; Li C; Yao S; Yin Y; Huang S; Fei B; Huang Z
J Exp Clin Cancer Res; 2021 Nov; 40(1):360. PubMed ID: 34782005
[TBL] [Abstract][Full Text] [Related]
15. miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.
Kontos CK; Tsiakanikas P; Avgeris M; Papadopoulos IN; Scorilas A
Mol Diagn Ther; 2017 Aug; 21(4):453-464. PubMed ID: 28405803
[TBL] [Abstract][Full Text] [Related]
16. LncRNA HOTAIR is a Prognostic Biomarker for the Proliferation and Chemoresistance of Colorectal Cancer via MiR-203a-3p-Mediated Wnt/ß-Catenin Signaling Pathway.
Xiao Z; Qu Z; Chen Z; Fang Z; Zhou K; Huang Z; Guo X; Zhang Y
Cell Physiol Biochem; 2018; 46(3):1275-1285. PubMed ID: 29680837
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.
Yan S; Tang Z; Chen K; Liu Y; Yu G; Chen Q; Dang H; Chen F; Ling J; Zhu L; Huang A; Tang H
J Exp Clin Cancer Res; 2018 Sep; 37(1):214. PubMed ID: 30176933
[TBL] [Abstract][Full Text] [Related]
18. Functional role of long non-coding RNA CASC19/miR-140-5p/CEMIP axis in colorectal cancer progression
Wang XD; Lu J; Lin YS; Gao C; Qi F
World J Gastroenterol; 2019 Apr; 25(14):1697-1714. PubMed ID: 31011255
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer.
Li Y; Yao Q; Zhang L; Mo S; Cai S; Huang D; Peng J
Oncologist; 2020 Dec; 25(12):e1968-e1979. PubMed ID: 32926498
[TBL] [Abstract][Full Text] [Related]
20. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]